Comparison of the effect of a product from Traditional Medicine with Metformin on oligomenorrhea in polycystic ovary syndrome
Phase 2
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT2015042521937N1
- Lead Sponsor
- School of Traditional Medicine and Materia Medica Research Center Shahid Beheshti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Patients with PCOS their main complaint is oligomenorrhea. Age 40-18 years, patient satisfaction, the absence of any systemic disease such as hyperinsulinemia, hyperandrogenism, diabetes mellitus, Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia and hyperthyroidism, hypertension, lack of pregnancy or within 6 weeks post-partum, lack of breastfeeding, non-hormonal drugs in the last month, no family history of breast and ovarian cancer. Exclusion criteria: Hormone therapy use, side effects, the need for other interventions and surgery, pregnancy occurred during the study, the patient's own request for exclusion.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Experience of menstural bleeding. Timepoint: Before intervention and 3, 4 month after intervention. Method of measurement: Question from patient.;Duration of bleeding. Timepoint: Before the intervention, month 3, 4. Method of measurement: Ask the patient.;Menstrual blood volume. Timepoint: Before the intervention, month 3,4. Method of measurement: Pictorial Blood Loss Assessment Chart (PBAC).
- Secondary Outcome Measures
Name Time Method Added at 2016-07-02: interval between menstural periods. Timepoint: Added at 2016-07-02: Before the intervention and 1, 2, and 3 months after the intervention. Method of measurement: Added at 2016-07-02: Asking from patients.